Emergency: Open 24hrs/365 days 
Emergency Call: (03) 9731 2000

Latest News

 

Clinical trial: Investigation of stem cells as treatment for spinal cord injuries in dogs



Do you know of a dog with a spinal cord injury that has resulted in severe neurological issues like loss of hindlimb mobility or paraplegia, loss of feeling or bowel and bladder dysfunction? We are exploring a new treatment for dogs based on the latest human medicine research, and you may be able to help.

Spinal cord injury (SCI) can be as devastating for dogs as for humans. The most common cause of SCI is intervertebral disc disease. To date no therapeutic method has been shown to successfully treat this disease in dogs with the most severe lesions, but neural derived stem cell therapies have shown promising results in humans. This trial will enable our veterinarians to explore the safety and feasibility of this treatment for dogs and evaluate improvements it may deliver to neural and motor function.

Eligible participant dogs will receive a free of charge initial consultation, treatment services, MRI imaging, and all research-related medical care and medications during the clinical trial.

This project has been approved by the Animal Ethics Committee of the University of Melbourne (#1714234).

Eligibility criteria

Candidate dogs must meet these criteria to take part in the trial:
  • Must be affected by a spinal cord injury with severe neurological deficits. These may include: loss of voluntary motor function of hindlimb or complete paraplegia, loss of sensation to the level of the spinal lesion, and dysfunction of bowels and bladder.
  • Must have been diagnosed or treated more than three months ago.
  • Older than 6 months of age
  • Less than 20kg body weight.

Enquire now

Please first ensure your dog meet the eligibility criteria above.

To enquire and register your interest, email Dr Matthias le Chevoir and the research team and include the following details:
  • “Investigation of stem cells as treatment for spinal cord injuries in dogs” in the subject line
  • Your first name and last name
  • Your phone number
  • Your email address
  • Your preferred method of contact (phone or email)
  • Your preferred time of contact (if by phone).
A member of our research team will be in touch to provide more information and to arrange for a suitable time.